Skip to main content
. 2020 Sep 14;11(11):3155–3167. doi: 10.1111/1759-7714.13634

Figure 1.

Figure 1

Information of HAX1 expression in TCGA database. (a) Expression of HAX1 in LUAD based on sample type. (b) Expression of HAX1 in LUAD based on patients’ smoking habits. (c) Expression of HAX1 in LUAD based on individual cancer stages. (d) Expression of HAX1 in LUAD based on patients’ gender. (e) Expression of HAX1 in LUAD based on patients’ age. (f) Expression of HAX1 in LUAD based on nodal metastasis status. (g) Expression of HAX1 in LUSC based on sample type. (h) Expression of HAX1 in LUSC based on patients’ smoking habits. (i) Expression of HAX1 in LUSC based on individual cancer stages. (jJ) Expression of HAX1 in LUAD based on patients’ gender. (k) Expression of HAX1 in LUSC based on patients’ age. (l) Expression of HAX1 in LUSC based on nodal metastasis status. LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; N0, no regional lymph node metastasis; N1, metastases in 1–3 axillary lymph nodes; N2, metastases in 4–9 axillary lymph nodes; N3, metastases in 10 or more axillary lymph nodes.